Cargando…
BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial
BACKGROUND: Bacterial vaginosis is associated with increased transmission of sexually transmitted infections, preterm labor, post-surgical infections, and endometritis. Current treatment for symptomatic bacterial vaginosis includes antibiotics, such as metronidazole, which are 70–80 % effective at o...
Autores principales: | Zeron Mullins, Melinda, Trouton, Konia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514959/ https://www.ncbi.nlm.nih.gov/pubmed/26210791 http://dx.doi.org/10.1186/s13063-015-0852-5 |
Ejemplares similares
-
Comparative Study of Intravaginal Metronidazole and Triple-Sulfa Therapy for Bacterial Vaginosis
por: Sobel, Jack D., et al.
Publicado: (1996) -
Development of Mucoadhesive Electrospun Scaffolds for Intravaginal Delivery of Lactobacilli spp., a Tenside, and Metronidazole for the Management of Bacterial Vaginosis
por: Ilomuanya, Margaret O., et al.
Publicado: (2023) -
Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial
por: Ross, Jonathan D. C., et al.
Publicado: (2023) -
Effect of metronidazole on vaginal microbiota associated with asymptomatic bacterial vaginosis
por: Ruiz-Perez, Daniel, et al.
Publicado: (2021) -
Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis
por: Armstrong-Buisseret, Lindsay, et al.
Publicado: (2019)